Wojewodzki Specjalistyczny Szpital Dzieciecy Im Sw Ludwika W Krakowie
- Address
- lock Available on a paid plan
Wojewodzki Specjalistyczny Szpital Dzieciecy Im Sw Ludwika - Pediatric Clinical Research Center
This specialized pediatric hospital in Krakow serves as a leading center for clinical research focused on childhood and adolescent conditions. The facility demonstrates particular expertise in conducting Phase 3 trials for innovative therapies targeting rare diseases and chronic pediatric conditions, with a strong emphasis on neurological disorders and rheumatological conditions in young patients.
- Migraine prevention and acute treatment studies in children and adolescents aged 6-18 years, including rimegepant efficacy trials
- Juvenile Idiopathic Arthritis (JIA) research, encompassing multiple subtypes including psoriatic arthritis and enthesitis-related arthritis
- Rare metabolic bone disorders, specifically hypophosphatasia (HPP) treatment studies in pediatric populations
- Neurological conditions including partial-onset focal seizures and Tourette Syndrome in pediatric and adolescent patients
The center's research portfolio reflects a comprehensive approach to pediatric care, with particular strength in long-term safety evaluations and pharmacokinetic studies of novel biologics and small molecules. The hospital's involvement in multiple international multicenter trials demonstrates its capability in managing complex study protocols while maintaining high standards of patient care and research integrity in vulnerable pediatric populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 10 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1Pfizer Inc.3active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Pfizer Inc.4trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Wojewodzki Specjalistyczny Szpital Dzieciecy Im Sw Ludwika W Krakowie
lock Showing 1 of 13 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of ALXN1850 in Pediatric Patients with Hypophosphatasia: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study | Alexion Pharmaceuticals Inc. | Phase III | Not Yet Recruiting | Apr 2024 | — |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Rimegepant | 3 | Unknown | 2021-08-31 | 2022-10-04 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.